Status:

TERMINATED

Effects of NIMV on the Health Status of Chronic Obstructive Pulmonary Disease (COPD )Patients

Lead Sponsor:

University of British Columbia

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

40-90 years

Phase:

PHASE3

Brief Summary

In this proposal, we will implement a randomized controlled trial to determine whether nocturnal NIMV applied for 3 months: 1) improves (disease-specific) health related quality of life (HRQL) of COPD...

Detailed Description

COPD is one of the fastest growing conditions in the world, affecting over 16 million people in the US and over 1 million in Canada and costing society over $23 billion per annum (in the US). Its prev...

Eligibility Criteria

Inclusion

  • A clinical diagnosis of COPD and meeting the American Thoracic Society's definition of COPD
  • Age 55 years of age or older;
  • A history of 10 pack-years or more of cigarette smoking;
  • FEV1 to FVC ratio of less than 70% and a postbronchodilator FEV1 of less than 50% of predicted (at baseline and after the run-in);
  • PaC02 of 45 mm Hg or greater measured at rest on room air (at baseline and after run-in)

Exclusion

  • Coexisting medical conditions that make survival for at least 6 months unlikely;
  • Refusal to participate;
  • Cognitive impairment which makes it impossible to obtain informed consent;
  • Patient on a lung transplant list;
  • Clinical history of left ventricular heart failure;
  • Body mass index of 35 kg/m2 or greater;
  • (Obstructive) apnea-hypopnea index (AHI) of \> 15 on polysomnography;
  • Evidence of Cheyne-Stokes respiration on polysomnography;
  • Impaired left ventricular ejection (LVEF of \< 40% as determined on 2-D echocardiography);
  • Patients who require rehospitalization, or an emergency visit for COPD during the run-in phase

Key Trial Info

Start Date :

January 1 2002

Trial Type :

INTERVENTIONAL

End Date :

December 1 2004

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00114426

Start Date

January 1 2002

End Date

December 1 2004

Last Update

August 17 2005

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Alberta Hospital

Edmonton, Alberta, Canada, T6J 2B7